Evaluation of the Cervical Canal With the Endocervical Brush

Hoffman, Mitchel S.; STERGHOS, STRATTON; GORDY, LORRAINE W.; Gunasekaran, Sivaselvi; Cavanagh, Denis

doi:10.1097/00006250-199310010-00020

Cited by 8 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Endocervical sampling using an endocervical brush shows a lower false-negative rate than ECC. [29][30][31][32] In the USA, ECC is often carried out in conjunction with cervical biopsy. It is used less frequently in Europe, where more often a diagnostic conization is preferred when an endocervical lesion has to be excluded.…”

Section: Endocervical Curettagementioning

confidence: 99%

European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1

et al. 2008

View full text Add to dashboard Cite

European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1The current paper presents the first part of Chapter 6 of the second edition of the European Guidelines for Quality Assurance in Cervical Cancer Screening. It provides guidance on how to manage women with abnormal cervical cytology. Throughout this article the Bethesda system is used for cervical cytology terminology, as the European guidelines have recommended that all systems should at least be translated into that terminology while cervical intraepithelial neoplasia (CIN) is used for histological biopsies (Cytopathology 2007; 18:213-9). A woman with a high-grade cytological lesion, a repeated low-grade lesion or with an equivocal cytology result and a positive human papillomavirus (HPV) test should be referred for colposcopy. The role of the colposcopist is to identify the source of the abnormal cells and to make an informed decision as to whether or not any treatment is required. If a patient requires treatment the colposcopist will decide which is the most appropriate method of treatment for each individual woman. The colposcopist should also organize appropriate follow-up for each woman seen. Reflex testing for high-risk HPV types of women with atypical squamous cells (ASC) of undetermined significance with referral for colposcopy of women who test positive is a first option. Repeat cytology is a second possibility. Direct referral to a gynaecologist should be restricted to special circumstances. Follow-up of low-grade squamous intraepithelial lesion is more difficult because currently there is no evidence to support any method of management as being optimal; repeat cytology and colposcopy are options, but HPV testing is not sufficiently selective, unless for older women. Women with high-grade squamous intraepithelial lesion (HSIL) or atypical squamous cells, cannot exclude HSIL (ASC-H) should be referred without triage. Women with glandular lesions require particular attention. In a subsequent issue of Cytopathology, the second part of Chapter 6 will be presented, with recommendations for management and treatment of histologically confirmed intraepithelial neoplasia and guidance for follow-up of special cases such as women who are pregnant, postmenopausal or immunocompromised.

show abstract

Section: Endocervical Curettagementioning

confidence: 99%

European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1

et al. 2008

View full text Add to dashboard Cite

show abstract

“…For example the endocervical brush may be more sensitive, but less specific, than formal endocervical curettage for diagnosis. [28] Cotton swabs and wooden spatulas tend to trap cells so they may never reach the slides. [29] Smears taken by cotton swabs or with plastic spatulas render fewer atypical cells than do endocervical brushes.…”

Section: Screeningmentioning

confidence: 99%

Screening of Cervical Cancer: Where Do We Go from Here?

Kuo

Goldberg

2003

Cancer Investigation

View full text Add to dashboard Cite

“…Numerous studies assessed also the sensitivity and specificity of ECC. It amounts to 49-82% and 75-97%, respectively [15][16][17][18]. What is also indicated is a high percentage of false negative and false positive results of ECC amounting to 45% and 25%, respectively [15].…”

Section: Discussionmentioning

confidence: 93%

Is routine performance of the uterine cervix canal curettage prior to the curettage of the uterine cavity justified?

Piątek

Lipa²,

Górska³

et al. 2017

Ginekol Pol

View full text Add to dashboard Cite

Objectives: Endocervical curettage (ECC) together with the dilatation and curettage of the uterine cavity (D & C) is routinely performed in everyday clinical practice. The aim of this study is to assess the rationale of the performance of ECC prior to D & C in indications other than abnormal uterine bleeding (AUB). Material and methods:Case histories of 736 patients after ECC performed in the 1 st Department of Obstetrics and Gynaecology, Medical University of Warsaw, were analyzed retrospectively, the indications for the procedure -age, menopausal status, parity, procedure operator's experience -as well as the result of the histopathology examination were taken into account. Three groups of patients were distinguished based on the indications for the procedure. Results:In 645 (87.6%) of cases normal histopathology results were obtained. 40 (5.4%) cases were abnormal. 31 cases of uterine cervix dysplasia were disclosed (CIN 1-20; CIN 2-5; CIN 3-6), 8 cases of endometrial cancer and 1 case of cancer of the uterine cervix were disclosed. In 51 (7%) of cases tissue material for histopathology examination was not obtained. In patients where ECC and D & C were performed due to indications other than abnormal bleeding from uterine cavity, no abnormal results were revealed. In addition, in this group the highest number of non-diagnostic ECCs was reported (11.59%; p < 0.05). Conclusions:In the case of endometrial biopsy for indications other than AUB routine ECC prior to D & C need not be performed.

show abstract

Evaluation of the Cervical Canal With the Endocervical Brush

Cited by 8 publications

References 0 publications

European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1

European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1

Screening of Cervical Cancer: Where Do We Go from Here?

Is routine performance of the uterine cervix canal curettage prior to the curettage of the uterine cavity justified?

Contact Info

Product

Resources

About